Month: <span>October 2021</span>

Home / 2021 / October
Glycerin is safe, effective in psoriasis model
Post

Glycerin is safe, effective in psoriasis model

by  Medical College of Georgia at Augusta University Dr. Wendy Bollag and first author Dr. Vivek Choudhary, MCG physiologist and molecular biologist. Credit: Michael Holahan, Augusta University Patients with psoriasis have reported that glycerin, an inexpensive, harmless, slightly sweet liquid high on the list of ingredients in many skin lotions, is effective at combatting their psoriasis...

Suicide and drug addiction in young people: Two interconnected phenomena
Post

Suicide and drug addiction in young people: Two interconnected phenomena

by  University of Montreal Credit: Unsplash/CC0 Public Domain The idea that alcohol, cannabis, and other drug abuse and dependence disorders lead to suicidal tendencies in adolescents and young adults is being challenged by the results of a new study in PLOS ONE conducted at Université de Montréal and CHU Sainte-Justine children’s hospital. “For the first time ever, our...

Cancer patients on chemotherapy likely not fully protected by COVID-19 vaccine, study finds
Post

Cancer patients on chemotherapy likely not fully protected by COVID-19 vaccine, study finds

by University of Arizona Health Sciences  Credit: Unsplash/CC0 Public Domain The COVID-19 pandemic has been an especially stressful time for cancer patients undergoing chemotherapy, which attacks not only the cancer, but also the immune cells needed to defend the body from infections. New research at the University of Arizona Health Sciences found that patients undergoing...

Post

CAR-T immunotherapy could be improved to kill solid tumors

by  Thomas Jefferson University Cancer cell during cell division. Credit: National Institutes of Health Immunotherapy, which harnesses the power of the body’s immune system to fight disease, is gaining huge traction in treating cancer. Chief among cancer immunotherapies is a treatment known as CAR-T or chimeric antigen receptor T cell therapy. CAR-T therapy has had great...

Moderna vaccine reduced viral load and protected against SARS-CoV-2 variants in new phase 3 trial
Post

Moderna vaccine reduced viral load and protected against SARS-CoV-2 variants in new phase 3 trial

By Jocelyn Solis-Moreira Sep 30 2021 Coronavirus research has shown that higher viral loads are associated with severe COVID-19 infection. But new results from the phase III Coronavirus Efficacy (COVE) clinical trial find the Moderna vaccine reduces severe acute respiratory coronavirus 2 (SARS-CoV-2) viral load and viral shedding. In addition to lower viral loads, the vaccine decreased...

Post

BLACK WOMEN HAVE NEARLY 3X HIGHER TRIPLE NEGATIVE BREAST CANCER

These types of cancer have a poor prognosis. The analysis of nearly 200,000 patients who received mammograms between 2006 and 2015 across three US health systems underscores the importance of understanding the heterogeneity of breast cancer risk factors for women of differing races, ages, and disease subtypes. The study appears in Cancer Medicine. The cohort included...

Post

University of Limerick, Ireland, study reveals link between Crohn’s disease and fatty tissue in the gut

UNIVERSITY OF LIMERICK New research led by University of Limerick in Ireland has revealed a direct link between fatty tissue and Crohn’s disease. The study, carried out by researchers at UL along with a team from University Hospital Limerick, is suggesting for the first time that Crohn’s disease, which is an inflammatory bowel condition, may...

First evidence of inflammatory micro clots in blood of individuals suffering from Long COVID
Post

First evidence of inflammatory micro clots in blood of individuals suffering from Long COVID

STELLENBOSCH UNIVERSITY IMAGE: FLUORESCENT IMAGE OF HEALTHY BLOOD PLASMA (LEFT) COMPARED TO THE MICRO CLOTS IN THE PLASMA FROM AN INDIVIDUAL WITH LONG-COVID ON THE RIGHT. CREDIT: RESIA PRETORIUS New research indicates that an overload of various inflammatory molecules, literally “trapped” inside insoluble microscopic blood clots (micro clots), might be the cause of some of...

UToledo scientists have developed an experimental vaccine against rheumatoid arthritis
Post

UToledo scientists have developed an experimental vaccine against rheumatoid arthritis

UNIVERSITY OF TOLEDO IMAGE: DR. RITU CHAKRAVARTI, ASSISTANT PROFESSOR IN THE UNIVERSITY OF TOLEDO COLLEGE OF MEDICINE AND LIFE SCIENCES, IS THE LEAD AUTHOR OF A NEW PAPER PUBLISHED IN THE PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES DETAILING THE CREATION OF AN EXPERIMENTAL VACCINE AGAINST RHEUMATOID ARTHRITIS. CREDIT: DANIEL MILLER | THE UNIVERSITY OF...